CSS LLC’s Albireo Pharma Inc ALBO Stock Holding History

CSS LLC’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-91,800	Closed	-$3.06M	–	982
2020 Q3	$3.06M	Buy	+91,800	New	+$2.67M	0.14%	142

Other funds holding ALBO

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

CSS LLC's ALBO Position: Q3 2022 in Review

CSS LLC sold out of Albireo Pharma Inc (ALBO) in Q3 2022, closing a stake of 12,143 shares — an estimated $251K sold.

CSS LLC first reported a position in ALBO in Q4 2020 and held it in 7 quarters. The position peaked at $390K in Q1 2022. 108 funds tracked by Wall St. Rank hold ALBO as of Q3 2022.

CSS LLC reported no remaining Albireo Pharma Inc position as of Q3 2022 after selling out during the quarter.
CSS LLC sold 12,143 Albireo Pharma Inc shares in Q3 2022, an estimated $251K.
CSS LLC first reported a position in Albireo Pharma Inc in Q4 2020 and held it in 7 quarters.
CSS LLC's Albireo Pharma Inc position peaked at $390K in Q1 2022.
108 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2022.

Based on CSS LLC's 13F filing for Q3 2022, filed 14 Nov 2022.